This announcement is a separate document:
國藥控股：(1) 建議更換核數師 (2) 建議授予董事會若干股東大會權力 (3) 建議委任獨立非執行董事 (4) 發行新股份之一般授權 (5) 購回H股之一般授權 (6) 建議發行公司債券 (7) 股東週年大會通告 (8) H股類別股東會通告 及 (9) 內資股類別股東會通告
SINOPHARM: (1) PROPOSED CHANGE OF AUDITORS (2) PROPOSED DELEGATION OF CERTAIN POWER OF THE GENERAL MEETING TO THE BOARD (3) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (4) GENERAL MANDATE TO ISSUE NEW SHARES (5) GENERAL MANDATE TO REPURCHASE
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.